An AI-driven model using 30 years of EHR data enhances screening for primary aldosteronism, a frequently underdiagnosed hypertension cause.
Key Details
- 1Study presented at ENDO 2026 by Mayo Clinic researchers, using Mayo Clinic Platform data from 1986–2025.
- 2AI model analyzed clinical variables: age, gender, ICD codes for hypertension/hypokalemia, blood pressure, potassium levels, and prescriptions.
- 3Model was developed with over 22,000 patients, tested on 225,887 hypertensive adults.
- 4XGBoost architecture predicted primary aldosteronism risk 12 months before diagnosis.
- 5At low-risk threshold, the model flagged >90% of cases while missing <10%, identifying about two-thirds for further screening.
Why It Matters

Source
EurekAlert
Related News

AI Framework Accelerates Aortic Aneurysm Risk Prediction from Imaging
Researchers developed BioPINN-LM, combining physics-informed neural networks and multimodal large language models to deliver fast, interpretable risk assessments for ascending thoracic aortic aneurysms.

Study Finds Patient Voices Missing in Generative AI Design for Oncology
A Flinders University-led review found patients and carers are rarely involved in shaping generative AI tools used in oncology.

Scripps Researchers Develop AI Foundation Model for ECG-Based Heart Disease Prediction
A new AI foundation model, ECG-CLIP, improves detection and prediction of multiple heart diseases using large-scale ECG and clinician note data.